GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION

What it is

GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “glycopyrrolate” and “glycopyrrolate oral solution”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “solution” and “liquid” and its route as oral.

FDA lists 7 labelers (the companies named on the label) for its NDCs, among them Camber Pharmaceuticals, Inc., Par Health USA, LLC and Sun Pharmaceutical Industries, Inc.

FDA lists it under 2 Established Pharmacologic Classes: Anticholinergic and Cholinergic Muscarinic Antagonist.

The NADAC file of 2026-10-14 prices it under 7 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $0.20 for 1 mL (1 × $0.2019 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

What NADAC measures · NADAC explanation codes

The 7 labelers

Other strengths, forms and brands

4 other products in the NADAC file share an FDA nonproprietary name with GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Compared with its class

The middle of its 7 NDCs’ NADAC prices is $0.2019 per ML filed.

Of the 12 other products in FDA’s Anticholinergic class priced per ML, 9 have a higher middle NADAC price and 3 a lower one. The one in the middle is TROPICAMIDE 1% EYE DROPS, at $0.55153 per ML filed (eff. 2026-09-23).

Of the 6 other products in FDA’s Cholinergic Muscarinic Antagonist class priced per ML, 4 have a higher middle NADAC price and 2 a lower one. The one in the middle is CUVPOSA 1 MG/5 ML SOLUTION, at $1.00673 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

We don’t know yet; the card above says why.

Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 1 mL? Is it lower than what I would pay through my insurance?
• How much is in the package I am getting? This page uses 1 mL; your package may hold a different amount.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.